Synthetic cannabinomimetics and ‘legal highs’

  title={Synthetic cannabinomimetics and ‘legal highs’},
  author={P. Maxwell},
  journal={Journal of Pharmacy Practice and Research},
  • P. Maxwell
  • Published 2014
  • Medicine
  • Journal of Pharmacy Practice and Research
Synthetic cannabinomimetic compounds present unique challenges for both healthcare professionals and lawmakers. A case of a 16‐year‐old girl who had been admitted to John Hunter Hospital as a result of a psychosis after ingestion of a synthetic cannabinomimetic and other drugs prompted the review of a range of hitherto unanticipated legislative and drug policy issues for consideration of healthcare professionals. The challenges and options open to legislators and law enforcement agencies to… Expand
2 Citations


Convulsions Associated with the Use of a Synthetic Cannabinoid Product
  • 101
  • PDF
Cannabinoid pharmacology: the first 66 years
  • R. Pertwee
  • Medicine
  • British journal of pharmacology
  • 2006
  • 447
  • PDF
The endocannabinoid system: a general view and latest additions
  • 451
Sydney: National Cannabis Prevention and Information Centre
  • Bulletin Series
  • 2012
Synthetic cannabinomimetics and 'legal highs'
    This activity has been accredited for 1 hour of Group 2 CPD activity (or 2 CPD credits) suitable for inclusion in an individual pharmacist's CPD plan